We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$17.4B
AUM Growth
+$2.11B
Cap. Flow
+$1.24B
Cap. Flow %
7.16%
Top 10 Hldgs %
29.6%
Holding
1,504
New
416
Increased
423
Reduced
335
Closed
326

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$125M
2
JNJ icon
Johnson & Johnson
JNJ
+$109M
3
TSLA icon
Tesla
TSLA
+$106M
4
DIS icon
Walt Disney
DIS
+$95.4M
5
KO icon
Coca-Cola
KO
+$79.4M

Sector Composition

Rank Sector Weight
1 Financials 24.18%
2 Industrials 13.69%
3 Energy 13.34%
4 Technology 11.86%
5 Materials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGFV
1101
DELISTED
Big 5 Sporting Goods
BGFV
$114K ﹤0.01%
+12,930
New +$149K
PASG icon
1102
Passage Bio
PASG
$14.7M
$114K ﹤0.01%
4,116
-276
-6% -$6.96K
NBP
1103
NovaBridge Biosciences American Depositary Shares
NBP
$220M
$113K ﹤0.01%
+27,113
New +$103K
ORGO icon
1104
Organogenesis Holdings
ORGO
$226M
$112K ﹤0.01%
+41,523
New +$121K
HLLY icon
1105
Holley
HLLY
$362M
$106K ﹤0.01%
+50,011
New +$157K
NL icon
1106
NLI Holdings
NL
$319M
$105K ﹤0.01%
15,462
-496
-3% -$3.7K
LGF.B
1107
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$105K ﹤0.01%
19,295
-105,828
-85% -$702K
DTIL icon
1108
Precision BioSciences
DTIL
$201M
$102K ﹤0.01%
2,852
-1,041
-27% -$41.1K
CARM
1109
DELISTED
Carisma Therapeutics
CARM
$96K ﹤0.01%
7,875
+737
+10% +$7.74K
UNIT
1110
Uniti Group
UNIT
$2.38B
$95.5K ﹤0.01%
+17,270
New +$119K
ILLM
1111
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$95.1K ﹤0.01%
61,600
+29,800
+94% +$49K
SUNW
1112
DELISTED
Sunworks, Inc.
SUNW
$94.9K ﹤0.01%
60,034
-60,110
-50% -$135K
INSG icon
1113
Inseego
INSG
$77.7M
$93.5K ﹤0.01%
11,098
+9,801
+756% +$147K
VWE
1114
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$93.3K ﹤0.01%
+28,609
New +$87.7K
KBAL
1115
DELISTED
Kimball International
KBAL
$92K ﹤0.01%
+14,155
New +$96.8K
NKTX icon
1116
Nkarta
NKTX
$165M
$91.9K ﹤0.01%
+15,335
New +$155K
CDXS icon
1117
Codexis
CDXS
$175M
$88.1K ﹤0.01%
+18,908
New +$104K
TRUE
1118
DELISTED
TrueCar
TRUE
$86.5K ﹤0.01%
34,475
-235,181
-87% -$489K
CCCC icon
1119
C4 Therapeutics
CCCC
$502M
$85.3K ﹤0.01%
+14,457
New +$120K
NATR icon
1120
Nature's Sunshine
NATR
$269M
$85K ﹤0.01%
10,221
+79
+0.8% +$669
ASMB icon
1121
Assembly Biosciences
ASMB
$594M
$85K ﹤0.01%
5,449
-5,364
-50% -$91.7K
CRD.B icon
1122
Crawford & Co Class B
CRD.B
$585M
$82.7K ﹤0.01%
15,569
-317
-2% -$1.77K
ACEL icon
1123
Accel Entertainment
ACEL
$1.01B
$79.3K ﹤0.01%
+10,300
New +$88.4K
LAW icon
1124
CS Disco
LAW
$297M
$78.9K ﹤0.01%
+12,487
New +$107K
IMGN
1125
DELISTED
Immunogen Inc
IMGN
$78.2K ﹤0.01%
+15,773
New +$85.5K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2022 Portfolio in Review

As of Q4 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,504 positions worth $17.4B, up 14% from $15.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.24B of net new capital in Q4 2022, opening 416 new positions and adding to 423 existing holdings. Its largest new stake was Citigroup: 1,437,772 shares worth $65M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Brookfield Infrastructure Partners, an estimated $71.3M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2022 buy was Citigroup: 1,437,772 shares worth $65M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Apple in Q4 2022, an estimated $125M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2022 reduction was Brookfield Infrastructure Partners, cutting an estimated $71.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Cigna in Q4 2022, selling an estimated $39.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $17.4B portfolio in Q4 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 416 new positions and closed 326 in Q4 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 14% quarter-over-quarter to $17.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.